Nataliya Agafonova - Jul 24, 2023 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Chief Medical Officer
Signature
/s/ Paul Lehr, attorney-in-fact
Stock symbol
LGVN
Transactions as of
Jul 24, 2023
Transactions value $
$0
Form type
4
Date filed
8/2/2023, 05:00 PM
Previous filing
Jul 13, 2023
Next filing
Aug 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Award $0 +30K $0.00 30K Jul 24, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024.
F2 Includes 22,500 Restricted Stock Units.